Copyright
©The Author(s) 2020.
World J Gastroenterol. May 28, 2020; 26(20): 2657-2668
Published online May 28, 2020. doi: 10.3748/wjg.v26.i20.2657
Published online May 28, 2020. doi: 10.3748/wjg.v26.i20.2657
Table 4 Differences in terms of perfusion parameters between responders and non-responders in the tumor tissue, determines through a dynamic contrast enhanced magnetic resonance imaging study for rectal cancer restaging (MR2) after chemo-radiotherapy
DCE-MRI parameters | Responders | Non-responders | P value |
RAE (mean ± SD) | 54 ± 20 | 129 ± 45 | 0.02 |
RVE (mean ± SD) | 73 ± 24 | 154 ± 39 | < 0.05 |
RLE (mean ± SD) | 82 ± 29 | 164 ± 35 | < 0.05 |
ME (mean ± SD) | 904 ± 429 | 1714 ± 427 | 0.03 |
TTP (mean ± SD) | 218 ± 18 | 196 ± 23 | 0.15 |
AUC (mean ± SD) | 120894 ± 50495 | 258022 ± 86469 | 0.02 |
- Citation: Ippolito D, Drago SG, Pecorelli A, Maino C, Querques G, Mariani I, Franzesi CT, Sironi S. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer. World J Gastroenterol 2020; 26(20): 2657-2668
- URL: https://www.wjgnet.com/1007-9327/full/v26/i20/2657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i20.2657